COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,684 Articles (22,913 medRxiv, 8,771 bioRxiv)

Most recent first Previous |  Page 2205: Articles 22041-22050  | Next

An attempt to optimize human resources allocation based on spatial diversity of COVID-19 cases in Poland
Jarynowski, A., Wojta-Kempa, M., Krzowski, L.
10.1101/2020.10.14.20090985 — Posted: 2020-10-15
Knowledge and practices towards COVID-19 among Palestinians during the COVID-19 outbreak: A second round cross-sectional survey
Qutob, N., Awartani, F., Asia, M., Abu Khader, I.
10.1101/2020.10.13.20211888 — Posted: 2020-10-15
Thermal Effect On The Persistence Of SARS-CoV2 Egyptian Isolates As Measured By Quantitative RT-PCR
Seadawy, M. G., Gad, A. F., Harty, B. E., Elhoseiny, M. F., Shamel, M. D., Soliman, Y. A.
10.1101/2020.10.13.20211771 — Posted: 2020-10-15
IgM autoantibodies recognizing ACE2 are associated with severe COVID-19
Casciola-Rosen, L., Thiemann, D. R., Andrade, F., Trejo Zambrano, M. I., Hooper, J. E., Leonard, E., Spangler, J., Cox, A. L., Machamer, C., Sauer, L., Laeyendecker, O., Garibaldi, B. T., Ray, S. C., Mecoli, C., Christopher-Stine, L., Gutierrez-Alamillo, L., Yang, Q., Hines, D., Clarke, W., Rothman, R. E., Pekosz, A., Fenstermacher, K., Wang, Z., Zeger, S. L., Rosen, A.
10.1101/2020.10.13.20211664 — Posted: 2020-10-15
Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020.
Kiti, M. C., Aguolu, O. G., Liu, C., Restrepo, A. M., Regina, R., Willebrand, K., Couzens, C., Bartelsmeyer, T., Bratton, K. N., Jenness, S. M., Riley, S., Melegaro, A., Ahmed, F., Malik, F., Lopman, B., Omer, S. B.
10.1101/2020.10.14.20212423 — Posted: 2020-10-15
Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
cross, r., Prasad, A. N., Borisevich, V., Woolsey, C., Agans, K. N., Deer, D. J., Dobias, N. S., Geisbert, J. B., Fenton, K. A., Geisbert, T. W.
10.1101/2020.10.14.340091 — Posted: 2020-10-14
The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation
Tidu, A., Janvier, A., Schaeffer, L., Sosnowski, P., Kuhn, L., Hammann, P., Westhof, E., Eriani, G., Martin, F.
10.1101/2020.10.14.339515 — Posted: 2020-10-14
Immunogenicity of novel mRNA COVID-19 vaccine MRT5500 in mice and non-human primates
Kalnin, K. V., Plitnik, T., Kishko, M., Zhang, J., Zhang, D., Beauvais, A., Anosova, N. G., Tibbitts, T., DiNapoli, J. M., Huang, P.-W. D., Huleatt, J., Vincent, D., Fries, K., Karve, S., Goldman, R., Gopani, H., Dias, A., Tran, K., Zacharia, M., Gu, X., Boeglin, L., Chivukula, S., Swearingen, R., Landolfi, V., Fu, T.-M., DeRosa, F., Casimiro, D.
10.1101/2020.10.14.337535 — Posted: 2020-10-14 Discussion: Onsite
Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19
Sarver, D. C., Wong, G. W.
10.1101/2020.10.13.337907 — Posted: 2020-10-14
Structural stability of SARS-CoV-2 degrades with temperature
Sharma, A., Preece, B., Swann, H., Fan, X., McKenney, R. J., Ori-McKenney, K. M., Saffarian, S., Vershinin, M.
10.1101/2020.10.12.336818 — Posted: 2020-10-14 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).